A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG

Arm A

"* Capecitabine~* Oxaliplatin~* Ziv-aflibercept"

DRUG

Arm B

Capecitabine Oxaliplatin Ziv-aflibercept

Trial Locations (1)

Hillman Cancer Center, Pittsburgh